Hers vs Noom Med: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Noom Med beats Hers overall, scoring 7.4/10 vs 7.3/10. Noom Med is more affordable at $99/mo vs $199/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose Noom Med for users who want a tiered entry into glp-1 care, from $99/mo m.
A side-by-side look at Hers and Noom Med to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#34 of 52The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership, alongside their existing compounded semaglutide and new compounded tirzepatide programs.
Visit HersNoom Med
#27 of 52Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.
Visit Noom Med| Feature | Hers | Noom Med |
|---|---|---|
| Our Score | 7.3/10 | 7.4/10 |
| Starting Price | $199/mo | $99/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand | Users who want a tiered entry into GLP-1 care, from $99/mo Microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program |
| Ranking | #34 | #27 |
| Get started | Visit Hers | Visit Noom Med |
Pros & Cons Compared
Hers
Pros
- +2026 Novo Nordisk partnership, FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership, read as access, not value
Noom Med
Pros
- +Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
- +New Microdose GLP-1Rx program ($99-149/mo), low-dose GLP-1 + biomarker monitoring for sensitive users
- +Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
- +Industry-leading behavioral coaching app with years of psychology-based weight loss methodology
Cons
- −Tiered pricing creates confusion, $69, $99-149, or $149-349 depending on tier
- −Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
- −Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
- −App coaching still requires real engagement, skip-prone users waste the behavioral value
Our Verdict
Noom Med edges out Hers with a score of 7.4/10 vs 7.3/10. If budget is your priority, Noom Med starts at $99/mo compared to Hers's $199/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose Noom Med if you want: users who want a tiered entry into glp-1 care, from $99/mo microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Hers nor Noom Med feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Hers or Noom Med tend to look at next.
- Hers vs Sprout Health$199/mo
- Hers vs Enhance MD$212/mo
- Hers vs MEDVi$179/mo
- Noom Med vs WeightWatchers (Sequence)$74/mo
- Noom Med vs Sprout Health$199/mo
- Noom Med vs Enhance MD$212/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.